Article
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Bearish
-55.0
−100 Bearish
0
+100 Bullish
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
CNBC Top Stories
Published
May 29, 2026 · 3:10 am
Article ID
qodogsj
Original URL
Open source
Sentiment Signal
Bearish
-55.0
−100Neutral+100
More Like This